Table 4.
GFR stage | MDRD-4 | CKD-EPI | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ml/min/1.73 m2 | ml/min/1.73 m2 | Creatinine clearance | Cockcroft-Gault | ||||||||||||||
Omittingcorrectionfor race | Omitting correction for race | ml/min/1.73 m2 | ml/min | ml/min/1.73 m2 | ml/min | ||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
Males | 1 | 269 | 75.8 | 139 | 39.2 | 280 | 78.9 | 189 | 53.2 | 123 | 34.7 | 99 | 27.9 | 38 | 10.7 | 34 | 9.6 |
2 | 80 | 22.5 | 195 | 54.9 | 68 | 19.2 | 151 | 42.5 | 179 | 50.4 | 183 | 51.5 | 244 | 68.7 | 201 | 56.6 | |
n = 355 | 3 | 6 | 1.7 | 19 | 5.4 | 7 | 2 | 14 | 3.9 | 49 | 13.8 | 65 | 18.3 | 70 | 19.7 | 115 | 32.4 |
4 | 0 | 0 | 2 | 0.6 | 0 | 0 | 1 | 0.3 | 4 | 1.1 | 8 | 2.3 | 3 | 0.9 | 5 | 1.4 | |
5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | |
Females | 1 | 396 | 67.2 | 190 | 32.3 | 448 | 76.1 | 295 | 50.1 | 232 | 39.4 | 148 | 25.1 | 135 | 22.9 | 91 | 15.5 |
2 | 184 | 31.2 | 350 | 59.4 | 132 | 22.4 | 265 | 45 | 285 | 48.4 | 278 | 47.2 | 329 | 55.9 | 259 | 44 | |
n = 589 | 3 | 9 | 1.5 | 47 | 8.0 | 9 | 1.5 | 29 | 4.9 | 71 | 12 | 157 | 26.7 | 122 | 20.7 | 230 | 39 |
4 | 0 | 0 | 2 | 0.3 | 0 | 0 | 0 | 0 | 1 | 0.2 | 6 | 1 | 3 | 0.5 | 9 | 1.5 | |
5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – | – | – | |
All | 1 | 665 | 70.4 | 329 | 34.8 | 728 | 77.1 | 484 | 51.3 | 355 | 37.6 | 247 | 26.2 | 173 | 18.3 | 125 | 13. 2 |
2 | 264 | 28 | 545 | 57.7 | 200 | 21.2 | 416 | 44.1 | 464 | 49.2 | 461 | 48.8 | 573 | 60.7 | 460 | 48.7 | |
n = 944 | 3 | 15 | 1.6 | 66 | 7.0 | 16 | 1.7 | 43 | 4.6 | 120 | 12.7 | 222 | 23.5 | 192 | 20.3 | 345 | 36.6 |
4 | 0 | 0 | 4 | 0.4 | 0 | 0 | 1 | 0.1 | 5 | 0.5 | 14 | 1.5 | 6 | 0.6 | 14 | 1.5 | |
5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – | – | – | – | |
All | 3–5 | 15 | 1.6 | 70 | 7.4 | 16 | 1.7 | 44 | 4.7 | 125 | 13.2 | 236 | 25.3 | 198 | 21.0 | 359 | 38.0 |